Showing results (91-100 of 101) with videos related to
Sort By:
Pageof 11
Cell|May 1, 2012
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolismHaoqiang Ying, Alec C Kimmelman, Costas A Lyssiotis, et al.Journal of Hematology & Oncology|April 17, 2025
KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinomaMahmoud Yousef, Abdelrahman Yousef, Mark W Hurd, et al.Elife|July 11, 2022
Metabolic requirement for GOT2 in pancreatic cancer depends on environmental contextSamuel A Kerk, Lin Lin, Amy L Myers, et al.The Journal of Clinical Investigation|February 27, 2018
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancerNa Zhao, Jin Cao, Longyong Xu, et al.Nature|March 29, 2019
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancerWantong Yao, Johnathon L Rose, Wei Wang, et al.Nature Medicine|March 6, 2019
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancerKirsten L Bryant, Clint A Stalnecker, Daniel Zeitouni, et al.Nature Medicine|June 3, 2020
Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancerKirsten L Bryant, Clint A Stalnecker, Daniel Zeitouni, et al.Science (New York, N.Y.)|September 7, 2023
Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitorsXiangdong Lv, Xuan Lu, Jin Cao, et al.Science Advances|March 13, 2024
Clonal dominance defines metastatic dissemination in pancreatic cancerI-Lin Ho, Chieh-Yuan Li, Fuchenchu Wang, et al.Nature Communications|July 31, 2021
PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinomaVirginia Giuliani, Meredith A Miller, Chiu-Yi Liu, et al.Pageof 11